Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Physician's Computer Net (PCNI) -- Ignore unavailable to you. Want to Upgrade?

To: Island Man who wrote (206)	3/3/1998 5:19:00 PM
From: ROY DEL	Read Replies (2) \| Respond to of 290

Looked like a buying opportunity to me as well. Hope to see a good rebound. I would like to have some questions answered though, as I was holding already. It'll be interesting to find out what the ***** going on and who's running things since the Pres. has been given/taken a leave of absence. Roy

To: Island Man who wrote (206)	3/3/1998 5:23:00 PM
From: Jonathan Feins	Read Replies (1) \| Respond to of 290

here is a post I made a year ago today! these guys are real slime. To: LEE SWIFT (43 ) From: Jonathan Feins Monday, Mar 3 1997 10:30PM EST Reply #44 of 206 I am the president of a medical billing company which uses a product that PCN acquired. I have clients in 6 states and bill $30 Million each year. My thoughts about PCN are mostly negative. Upon acquiring companies, their main objective is to get users of the software they acquire to migrate (switch) to the PCN product. I was approached and told it would cost $40,000 to switch to their software and that if I did not switch I would be using a product which would no longer be enhanced or supported in the future. What PCN acquires when they take over a software competitor is a client list. They expect the migration to the PCN product and try to strong arm you into making the move. What PCN found out was that the number of people who are switching to their product is not living up to their expectations and there are a lot of unhappy new clients. I think management has been deceitful and misleading about their intentions and that once they stop acquiring companies the stock will go the way Medaphis (MEDA) went. The PCN product is overpriced and managed by a less than honest group of individuals. Jon